GlobeNewswire

Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
10/09/2026
Results from the planned interim analysis of the Phase 3 REZILIENT3 trial of zipalertinib plus chemotherapy in first-line EGFR exon 20 insertion mutation NSCLC to be presented in Presidential Symposium 2 on Sunday, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
10/09/2026
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026
10/09/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, United States), September 10, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver [...]
GENFIT annonce sa participation à la H.C. Wainwright 28th Annual Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, États-Unis), le 10 septembre 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie [...]
Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026
10/09/2026
Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
10/09/2026
Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: [...]
Rad Source Technologies Introduces Sterile Insect Farms™
10/09/2026
Now offering Sterile Mosquitoes for Non-Chemical & Non-GMO Vector Control BUFORD, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies, a leading innovator in X-ray solutions for life sciences, is proud [...]
Tecan to participate in upcoming Investor Conference
10/09/2026
Männedorf, Switzerland, September 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will participate in the following investor conference next week: 24 th Annual Morgan Stanley Healthcare [...]
Vanquish Brands Partners with Select BC Craft Growers to Bring Premium Cannabis to Markets Across Canada Via the Pistol and Paris Brand
10/09/2026
AGASSIZ, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vanquish Holdings Inc. (“Vanquish”), operating under the Vanquish Brands name, is a Canadian cannabis house-built Legacy to Legal™, combining the standards, [...]
Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York
10/09/2026
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today [...]
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
10/09/2026
Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30% SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada [...]
Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company
10/09/2026
New production framework designed to support continuous manufacturing, greater operating efficiency and long-term program visibility LITTLETON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc [...]
Fortrea to Participate in September Investor Conferences
10/09/2026
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor [...]
Tria Federal Promotes Diana Ceban to Chief Growth Officer to Align Growth Strategy Around the Healthcare Trilemma
10/09/2026
Ceban to lead enterprise growth centered on helping federal health agencies balance the competing pressures of cost, quality and access to care ARLINGTON, Va., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Tria Federal today [...]
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
10/09/2026
Health Canada-authorized trial to evaluate a single supervised dose of natural psilocybin, with dosing expected to be completed by the end of 2027 Up to 200 participants at sites across Canada, among the largest studies [...]
Cannabix Technologies Deploys BreathLogix Alcohol Monitoring System with Lake County Community Corrections in Indiana's Second-Most Populous County
10/09/2026
VANCOUVER, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana and alcohol breath testing technologies, is pleased to announce the [...]
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
10/09/2026
DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure [...]
Vistagen to Present at Psych Congress 2026
10/09/2026
Poster presentation highlights positive efficacy signal for fasedienol nasal spray in study participants with very severe social anxiety disorder SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vistagen [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum